Newsletter summary
[announcement selected: Azure biosynthesis Biotechnology Innovation Laboratory has fewer R & D projects and does not have the conditions for industrialization] Securities Times e Company NewsBingomenowFujilai: the income of R-lipoic acid produced by biological enzyme catalysis is relatively small, and there is no clear plan to expand production.Bingomenow...
Text of news flash
[announcement selection: Azure Biosynthesis Biotechnology Innovation Laboratory has fewer R & D projects and does not have the conditions for industrialization] Securities Times e, Fuji Lai: the income of R-lipoic acid produced by biological enzyme catalysis is relatively small, and there is no clear plan to expand production; four-plate azure biology: the company's synthetic biotechnology innovation laboratory has fewer R & D projects and does not have the conditions for industrialization. Yutong bus: bus sales in April increased by 62.13% compared with the same period last year; Huanrui Century: the company's revenue from the film "peacekeeping and Riot Prevention team" was about 300000 yuan; Muyuan shares: the sales income of live pigs in April was 9.153 billion yuan, and the average sales price of commercial pigs was 14.80 yuan / kg; Vanke's April contract sales amount was 20.89 billion yuan. Sea seed industry: sign the strategic cooperation agreement for the joint construction of Denghai Maize Industry Research Institute of Shandong Agricultural University; Salt Lake shares: Qinghai State Investment plans to carry out strategic cooperation with China Minmetals, which may involve the change of the actual controller of the company.
